Follow-up after ED visits for opioid use disorder: Do they reduce future overdoses?

IF 3.7 2区 医学 Q1 PSYCHOLOGY, CLINICAL Journal of Substance Abuse Treatment Pub Date : 2022-11-01 DOI:10.1016/j.jsat.2022.108807
{"title":"Follow-up after ED visits for opioid use disorder: Do they reduce future overdoses?","authors":"","doi":"10.1016/j.jsat.2022.108807","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Follow-up visits within 7 days of an emergency department<span> (ED) visit related to opioid use disorder (OUD) is a key measure of treatment quality, but we know little about its protective effect on future opioid-related overdoses. The objective this paper is to examine the rate of 7-day follow-up after an OUD-related ED visit and the association with future overdoses.</span></p></div><div><h3>Methods</h3><p>Retrospective analysis of Medicaid enrollees in 11 states that had an OUD-related ED visit from 2016 through 2018. Each state used Cox proportional hazard models to estimate the association between having a follow-up visit within 7 days of an OUD-related ED visit, and an overdose within 6 months of the ED visit. State analyses were pooled to generate global estimates using random effects meta-analysis.</p></div><div><h3>Results</h3><p>Among 114,945 Medicaid enrollees with an OUD-related ED visit, 15.7% had a follow-up visit within 7 days. State-specific rates varied from 7.2% to 22.4% across the 11 states. Compared to those with no follow-up visit, enrollees with a follow-up visit were more likely to be female, non-Hispanic White, less likely to have had an overdose or other substance use disorder at the time of the ED visit, and much more likely to have been receiving MOUD treatment prior to the ED visit. Global estimates based on multivariate analysis showed that having a 7-day follow-up visit was associated with a lower likelihood of overdose within 6 months of the index ED visit (HR = 0.91, CI = 0.84, 0.99). However, states had considerable heterogeneity in this association, with only two states having statistically significant results.</p></div><div><h3>Conclusions</h3><p>Among Medicaid enrollees with OUD, having a follow-up visit 7 days after an ED visit is protective against fatal or nonfatal overdose within 6 months, although the association varies considerably across states. Although the association with future overdoses was relatively modest, both practitioners and policymakers should seek to increase the number of Medicaid enrollees with OUD who receive follow-up care within 7 days after an ED visit.</p></div>","PeriodicalId":17148,"journal":{"name":"Journal of Substance Abuse Treatment","volume":"142 ","pages":"Article 108807"},"PeriodicalIF":3.7000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Substance Abuse Treatment","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0740547222000897","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 2

Abstract

Introduction

Follow-up visits within 7 days of an emergency department (ED) visit related to opioid use disorder (OUD) is a key measure of treatment quality, but we know little about its protective effect on future opioid-related overdoses. The objective this paper is to examine the rate of 7-day follow-up after an OUD-related ED visit and the association with future overdoses.

Methods

Retrospective analysis of Medicaid enrollees in 11 states that had an OUD-related ED visit from 2016 through 2018. Each state used Cox proportional hazard models to estimate the association between having a follow-up visit within 7 days of an OUD-related ED visit, and an overdose within 6 months of the ED visit. State analyses were pooled to generate global estimates using random effects meta-analysis.

Results

Among 114,945 Medicaid enrollees with an OUD-related ED visit, 15.7% had a follow-up visit within 7 days. State-specific rates varied from 7.2% to 22.4% across the 11 states. Compared to those with no follow-up visit, enrollees with a follow-up visit were more likely to be female, non-Hispanic White, less likely to have had an overdose or other substance use disorder at the time of the ED visit, and much more likely to have been receiving MOUD treatment prior to the ED visit. Global estimates based on multivariate analysis showed that having a 7-day follow-up visit was associated with a lower likelihood of overdose within 6 months of the index ED visit (HR = 0.91, CI = 0.84, 0.99). However, states had considerable heterogeneity in this association, with only two states having statistically significant results.

Conclusions

Among Medicaid enrollees with OUD, having a follow-up visit 7 days after an ED visit is protective against fatal or nonfatal overdose within 6 months, although the association varies considerably across states. Although the association with future overdoses was relatively modest, both practitioners and policymakers should seek to increase the number of Medicaid enrollees with OUD who receive follow-up care within 7 days after an ED visit.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿片类药物使用障碍急诊科就诊后的随访:它们能减少未来的过量用药吗?
与阿片类药物使用障碍(OUD)相关的急诊科(ED) 7天内随访是衡量治疗质量的关键指标,但我们对其对未来阿片类药物相关过量的保护作用知之甚少。这篇论文的目的是检查与oud相关的急诊科就诊后7天的随访率及其与未来过量用药的关系。方法回顾性分析2016年至2018年11个州的医疗补助计划参保者与oud相关的急诊科就诊。每个州都使用Cox比例风险模型来估计与oud相关的ED就诊后7天内的随访与ED就诊后6个月内的过量用药之间的关系。使用随机效应荟萃分析,将各州分析汇总以产生全球估计。结果在114,945名接受医疗补助的患者中,15.7%的患者在7天内进行了随访。11个州的具体比率从7.2%到22.4%不等。与那些没有随访的人相比,随访的参与者更有可能是女性,非西班牙裔白人,在急诊室就诊时服用过量或其他物质使用障碍的可能性更小,在急诊室就诊前接受mod治疗的可能性更大。基于多变量分析的全球估计显示,7天随访与指数ED访问后6个月内服药过量的可能性较低相关(HR = 0.91, CI = 0.84, 0.99)。然而,各州在这一关联中存在相当大的异质性,只有两个州的结果具有统计学意义。结论:在接受医疗补助的OUD患者中,在ED就诊后7天进行随访可预防6个月内致命性或非致命性用药过量,尽管各州之间的相关性差异很大。尽管与未来过量用药的关联相对较小,但从业人员和政策制定者都应寻求增加在ED就诊后7天内接受随访治疗的OUD患者的医疗补助登记人数。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.60
自引率
10.30%
发文量
220
期刊介绍: The Journal of Substance Abuse Treatment (JSAT) features original reviews, training and educational articles, special commentary, and especially research articles that are meaningful to the treatment of alcohol, heroin, marijuana, and other drugs of dependence. JSAT is directed toward treatment practitioners from all disciplines (medicine, nursing, social work, psychology, and counseling) in both private and public sectors, including those involved in schools, health centers, community agencies, correctional facilities, and individual practices. The editors emphasize that JSAT articles should address techniques and treatment approaches that can be used directly by contemporary practitioners.
期刊最新文献
Not in my treatment center: Leadership's perception of barriers to MOUD adoption Peer support to reduce readmission in Medicaid-enrolled adults with substance use disorder National trends in buprenorphine prescribing before and during the COVID-19 pandemic A qualitative analysis of barriers to opioid agonist treatment for racial/ethnic minoritized populations An intervention pilot to facilitate harm reduction service decentralization in Vietnam
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1